<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://plaintiffwire.com/release/georgiamune-et-le-groupe-menarini-concluent-un-accord-mondial-exclusif-de-licenc-a348df</loc><news:news><news:publication><news:name>PlaintiffWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T21:15:00.000Z</news:publication_date><news:title>Georgiamune et le groupe Menarini concluent un accord mondial exclusif de licence et de collaboration sur le GIM-621, un agent immuno-oncologique oral novateur</news:title></news:news></url>
<url><loc>https://plaintiffwire.com/release/valaris-investor-alert-kahn-swick-foti-llc-investigates-adequacy-of-price-and-pr-d43214</loc><news:news><news:publication><news:name>PlaintiffWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-22T19:51:00.000Z</news:publication_date><news:title>Valaris Investor Alert: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Valaris Limited - VAL</news:title></news:news></url>
</urlset>